Publisher Full Text
Validation of an enzyme-linked immunosorbent assay that detects Histoplasma capsulatum antigenuria in Colombian patients with AIDS for diagnosis and follow-up during therapy.Clin Vaccine Immunol. 2014 Sep; 21(9):1364-8.CV
Abstract
We validated an antigen capture enzyme-linked immunosorbent assay (ELISA) in Colombian persons with AIDS and proven histoplasmosis and evaluated the correlation between antigenuria and clinical improvement during follow-up. The sensitivity of the Histoplasma capsulatum ELISA was 86%, and the overall specificity was 94%. The antigen test successfully monitored the response to therapy.
Links
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Validation Study
Language
eng
PubMed ID
25008902
Citation
Caceres, Diego H., et al. "Validation of an Enzyme-linked Immunosorbent Assay That Detects Histoplasma Capsulatum Antigenuria in Colombian Patients With AIDS for Diagnosis and Follow-up During Therapy." Clinical and Vaccine Immunology : CVI, vol. 21, no. 9, 2014, pp. 1364-8.
Caceres DH, Scheel CM, Tobón AM, et al. Validation of an enzyme-linked immunosorbent assay that detects Histoplasma capsulatum antigenuria in Colombian patients with AIDS for diagnosis and follow-up during therapy. Clin Vaccine Immunol. 2014;21(9):1364-8.
Caceres, D. H., Scheel, C. M., Tobón, A. M., Ahlquist Cleveland, A., Restrepo, A., Brandt, M. E., Chiller, T., & Gómez, B. L. (2014). Validation of an enzyme-linked immunosorbent assay that detects Histoplasma capsulatum antigenuria in Colombian patients with AIDS for diagnosis and follow-up during therapy. Clinical and Vaccine Immunology : CVI, 21(9), 1364-8. https://doi.org/10.1128/CVI.00101-14
Caceres DH, et al. Validation of an Enzyme-linked Immunosorbent Assay That Detects Histoplasma Capsulatum Antigenuria in Colombian Patients With AIDS for Diagnosis and Follow-up During Therapy. Clin Vaccine Immunol. 2014;21(9):1364-8. PubMed PMID: 25008902.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Validation of an enzyme-linked immunosorbent assay that detects Histoplasma capsulatum antigenuria in Colombian patients with AIDS for diagnosis and follow-up during therapy.
AU - Caceres,Diego H,
AU - Scheel,Christina M,
AU - Tobón,Angela M,
AU - Ahlquist Cleveland,Angela,
AU - Restrepo,Angela,
AU - Brandt,Mary E,
AU - Chiller,Tom,
AU - Gómez,Beatriz L,
Y1 - 2014/07/09/
PY - 2014/7/11/entrez
PY - 2014/7/11/pubmed
PY - 2015/9/1/medline
SP - 1364
EP - 8
JF - Clinical and vaccine immunology : CVI
JO - Clin Vaccine Immunol
VL - 21
IS - 9
N2 - We validated an antigen capture enzyme-linked immunosorbent assay (ELISA) in Colombian persons with AIDS and proven histoplasmosis and evaluated the correlation between antigenuria and clinical improvement during follow-up. The sensitivity of the Histoplasma capsulatum ELISA was 86%, and the overall specificity was 94%. The antigen test successfully monitored the response to therapy.
SN - 1556-679X
UR - https://www.unboundmedicine.com/medline/citation/25008902/Validation_of_an_enzyme_linked_immunosorbent_assay_that_detects_Histoplasma_capsulatum_antigenuria_in_Colombian_patients_with_AIDS_for_diagnosis_and_follow_up_during_therapy_
L2 - http://cvi.asm.org/cgi/pmidlookup?view=long&pmid=25008902
DB - PRIME
DP - Unbound Medicine
ER -